Inhibitory effect of caffeic acid phenethyl ester on mice bearing tumor involving angiostatic and apoptotic activities

Chemico-Biological Interactions

Volumn 186, Issue 2, 2010, Pages 152-156

  El Refaei, Mohamed F ^a   El Naa, Mona M ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b October University for Modern Sciences and Arts   (Egypt)

Author keywords

Anti angiogenesis; Anti tumor; Apoptosis; DNA fragmentation

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; ENDOSTATIN; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DNA FRAGMENTATION; EHRLICH ASCITES TUMOR; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAFFEIC ACIDS; CARCINOMA, EHRLICH TUMOR; DNA FRAGMENTATION; ENDOSTATINS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENYLETHYL ALCOHOL;

ANIMALIA; MUS;

EID: 77953542272     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.04.019     Document Type: Article

References (39)

1. Lingwood R., Boyle P., Milburn A., Ngoma T., Arbuthnott J., McCaffrey R., Kerr S., Kerr D. The challenge of cancer control in Africa. Nat. Rev. Cancer 2008, 8:398-403.
2. Jang J., Kay C., You C., Kim C., Bae S., Choi J., Yoon S., Han C., Jung H., Choi I. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:412-418.
3. Kane A., Yang I. Interferon-gamma in brain tumor immunotherapy. Neurosurg. Clin. N. Am. 2010, 21:77-86.
4. Refaely Y., Weissberg D. Surgical management of tracheal tumors. Ann. Thorac. Surg. 1997, 64:1429-1432.
5. Hong-Fang J., Xue-Juan L., Hong-Yu Z. Natural products and drug discovery. EMBO Rep. 2009, 10:194-200.
6. Aso K., Kanno S., Tadano T., Satoh S., Ishikawa M. Inhibitory effect of propolis on the growth of human leukemia U937. Biol. Pharm. Bull. 2004, 27:727-730.
7. Scheller S., Krol W., Swiacik J., Owczarek S., Gabrys J., Shani J. Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin. Z. Naturforsch C. 1989, 44:1063-1065.
8. Orsolic N., Sver L., Terzić S., Basić I. Peroral application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and their influence on immunological and antitumour activity. Vet. Res. Commun. 2005, 29:575-793.
9. Tseng T., Lee Y. Evaluation of natural and synthetic compounds from East Asiatic folk medicinal plants on the mediation of cancer. Anticancer Agents Med. Chem. 2006, 6:347-365.
10. Chen M., Keng P., Lin P., Yang C., Liao S., Chen W. Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer 2005, 5:1-9.
11. Borrelli F., Izzo A., Carlo G., et al. Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon. Fitoterapia 2002, 73:S38-S43.
12. Fidan H., Sahin O., Yavuz Y., et al. Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats. Crit. Care Med. 2007, 23. [Epub ahead of print].
13. Motomura M., Kwon K., Suh S., et al. Propolis induces cell cycle arrest and apoptosis in human leukemic U937 cells through Bcl-2/Bax regulation. Environ. Toxicol. Pharmacol. 2008, 26:61-67.
14. Park J., Lee J., Kim H., et al. Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. Int. Immunopharmacol. 2004, 4:429-436.
15. Kubista E., Planellas G., Dowsett M., et al. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEMTrial. Clin. Cancer Res. 2007, 13:4185-4190.
16. Van't Land B., Blijlevens N., Marteijn J., et al. Role of curcumin and the inhibition of NF-κB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 2004, 18:276-284.
17. Jae-Jun S., Cho J., Soon-Jae H., Cho C., Seok-Won P., Sung-Won C. Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells. Acta Otolaryngol. 2008, 128:1303-1307.
18. Guang-Yi W., Bai J., Xu W., Jian-Hua G. Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J. Gastroenterol. 2005, 11:3830-3833.
19. Tian L., Yun-Guang L., De-Min P. Metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol. Obstet. Invest. 2006, 62:229-235.
20. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
21. O'Reilly M., Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
22. Sim B. Angiostatin and endostatin: endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth. Angiogenesis 1998, 2:37-48.
23. Fang F., Chen P., Wu X., et al. Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion. J. Cancer Res. Clin. Oncol. 2009, 135:1149-1157.
24. Wu X. New strategy of antiangiogenic therapy for hepatocellular carcinoma. Neoplasma 2008, 55:472-481.
25. Halfter W., Dong S., Schurer B., Cole G. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 1998, 25:404-412.
26. Dhanabal M., Ramchandran R., Waterman M., et al. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 1999, 274:11721-11726.
27. Dasyukevich O., Solyanik G. Comparative study of anticancer efficacy of aonitine-containing agent bc1 against ascite and solid forms of Ehrlich's carcinoma. Exp. Oncol. 2007, 29:317-319.
28. Lee I., Boucher Y., Jain R. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res. 1992, 52:3237-3240.
29. Nicoletti I., Migliorati G., Pagliacci M., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 3:271-279.
30. Aref S., Salama O., Shamaa S., El-Refaei M., Mourkos H. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia. Hematology 2007, 12:319-324.
31. Jung W., Lee D., Choi Y., et al. Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sci. 2008, 82:797-805.
32. Zheng Z., Xue G., Grunberger D., Prystowsky J. Caffeic acid phenethyl ester inhibits proliferation of human keratinocytes and interferes with the EGF regulation of ornithine decarboxylase. Oncol. Res. 1995, 7:445-452.
33. Celik S., Gorur S., Aslantas O., Erdogan S., Ocak S., Hakverdi S. Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats. Mol. Cell. Biochem. 2007, 297:131-138.
34. Cavaliere V., Papademetrio D., Lorenzetti M., et al. Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells. Transl. Oncol. 2009, 2:46-58.
35. Gu J., Gadonski G., Wang J., Makey I., Adair T. Exercise increases endoststin in circulation of health volunteers. BMC Phys. 2004, 7:273-279.
36. Kirsch M., Schackert G., Black P. Metastasis and angiogenesis. Cancer Treat. Res. 2004, 117:285-304.
37. Suzuki I., Hayashi I., Takaki T., Groveman D., Fujimiya Y. Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biother. Radiopharm. 2002, 17:553-562.
38. Melani C., Sangaletti S., Barazzetta F., Werb Z., Colombo M. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res. 2007, 67:11438-11446.
39. Schuch G., Oliveira-Ferrer L., Loges S., et al. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. Leukemia 2005, 19:1312-1327.